Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?
- Trishna Bharadia
- , Jo Vandercappellen
- , Tanuja Chitnis
- , Piet Eelen
- , Birgit Bauer
- , Giampaolo Brichetto
- , Andrew Lloyd
- , Hollie Schmidt
- , Miriam King
- , Jennifer Fitzgerald
- , Thomas Hach
- , Jeremy Hobart*
*Corresponding author for this work
- Novartis
- Harvard University
- National Multiple Sclerosis Center
- Manufaktur für Antworten UG
- Associazione Italiana Sclerosi Multipla
- Acaster Lloyd Consulting Ltd
- Accelerated Cure Project for Multiple Sclerosis
Research output: Contribution to journal › Article › peer-review
25
Downloads
(Pure)